Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension

Blood Pressure Monitoring
Joan BayóBotey Albert

Abstract

To determine the diagnostic performance of home blood pressure self-monitoring in white-coat hypertension using a 3-day reading program. One hundred and ninety nontreated patients recently diagnosed with mild-moderate hypertension, selected consecutively at four primary healthcare centers in the city of Barcelona, were included. Each patient underwent morning and night home blood pressure self-monitoring with readings in triplicate for three consecutive days, followed by 24-h ambulatory blood pressure monitoring. The normality cut-off point value for home blood pressure self-monitoring and daytime ambulatory blood pressure monitoring was 135/85 mmHg. Sixty-three patients were diagnosed with white-coat hypertension with home blood pressure self-monitoring (34.8%; 95% confidence interval: 27.9-42.2) and 74 with ambulatory blood pressure monitoring (41.6%; 95% confidence interval: 33.7-48.4). No statistically significant differences were observed between home blood pressure self-monitoring values and those of diurnal ambulatory blood pressure monitoring [137.4 (14.3)/82.1 (8.3) mmHg vs. 134.8 (11.3)/81.3 (9.5) mmHg]. Home blood pressure self-monitoring diagnostic performance parameters were sensitivity 50.0% (95% confidence interv...Continue Reading

References

Jul 15, 1998·Journal of Hypertension·G S StergiouT D Mountokalakis
Jan 8, 1999·American Journal of Hypertension·T MengdenH Vetter
Dec 14, 1999·BMJ : British Medical Journal·A NordmannE Battegay
Jul 18, 2000·Occupational and Environmental Medicine·J A StaessenR H Fagard
Jan 9, 2003·American Journal of Hypertension·Paolo VerdecchiaUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Mar 27, 2003·Journal of Hypertension·Gianfranco Parati, George S Stergiou
Mar 27, 2003·Journal of Hypertension·Elly Den HondUNKNOWN THOP investigators
Apr 26, 2003·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee

❮ Previous
Next ❯

Citations

Feb 24, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Efthimia G NasothimiouGeorge S Stergiou
Jun 14, 2014·Current Hypertension Reports·George S StergiouAngeliki Ntineri
Apr 9, 2016·Methodist DeBakey Cardiovascular Journal·Aldo J Peixoto
Jun 15, 2013·Clinical and Experimental Pharmacology & Physiology·Yutaka ImaiMichihiro Satoh
Aug 22, 2014·American Journal of Hypertension·Elizabeth S MuxfeldtGil F Salles
Oct 14, 2010·American Journal of Hypertension·George S Stergiou, Ioannis A Bliziotis
Feb 28, 2008·Journal of Hypertension·Ernest VinyolesUNKNOWN Spanish Society of Hypertension ABPM Registry
Apr 29, 2015·Journal of Hypertension·George S Stergiou, Angeliki Ntineri
May 29, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masanori Munakata
May 29, 2020·Journal of Human Hypertension·Margaret ConstantiMark Glover
Apr 28, 2021·JAMA : the Journal of the American Medical Association·Janelle M Guirguis-BlakeMeghan Soulsby Weyrich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.